The Antibody Lab has various contract models in a flexible way according to its partners' needs. We offer fee-based services, co-development and out licensing of products.
We are offering currently partnerships in two areas:
in vitro diagnostics development and Cell Line development .
The Antibody Lab is involved in the utilization and validation of new innovative biomarkers (= laboratory measurements that reflect the activity of a disease process) in cooperation with universities, small and medium biotech companies and with leading research centers worldwide.
In cooperation with academic partners, The Antibody Lab performs protein engineering and expression.
A long term commercial cooperation partner is Biomedica Medizinprodukte GmbH & Co KG. The Antibody Lab is involved in the selection of the assays to be developed for Biomedica. The task is to support Biomedica in becoming market leader for clinical research grade immunoassays in the fields of bone metabolism, cardiovascular and kidney disease.
A close scientific partner is the Medical University Vienna, Center for Physiology and Pharmacology. Together with Prof. Michael Freissmuth and Prof. Emilio Casanova, The Antibody Lab is performing research for improving Secretory IgA as a therapeutic immunoglobulin class.